What are the common causes of Candida skin infections. How can you identify Candida infection on the skin. What are effective treatment options for cutaneous candidiasis. When should you seek medical attention for a potential Candida skin infection.

Understanding Candida Infections: A Comprehensive Overview

Candida infections, also known as candidiasis or moniliasis, are fungal infections caused by various species of Candida yeast. These opportunistic pathogens can affect different parts of the body, including the skin, mucous membranes, and internal organs. Cutaneous candidiasis, which refers to Candida infections of the skin, is a common manifestation that can cause discomfort and concern for many individuals.

Candida albicans is the most prevalent species responsible for these infections, but other species like C. glabrata, C. tropicalis, and C. parapsilosis can also be culprits. Understanding the nature of these infections, their causes, and treatment options is crucial for effective management and prevention.

The Pathophysiology of Cutaneous Candidiasis

Cutaneous candidiasis develops when Candida yeast overgrows on the skin. This overgrowth can occur due to various factors that disrupt the skin’s natural balance or compromise the immune system. The pathophysiology of cutaneous candidiasis involves several key mechanisms:

• Adhesion: Candida species, particularly C. albicans, possess adhesion molecules that allow them to attach to host cells. For example, the Hwp1 protein enables C. albicans to bind to epithelial cells.
• Invasion: Once attached, Candida can penetrate the skin barrier through various means, including the production of enzymes that break down tissue.
• Immune evasion: Candida species have developed strategies to evade the host’s immune response, such as altering their cell wall composition.
• Biofilm formation: In some cases, Candida can form biofilms on the skin surface, making infections more resistant to treatment.

Is pH important in Candida infections? Indeed, the pH of the host environment plays a crucial role in Candida virulence. Research has shown that C. albicans can adapt to different pH levels, which affects its gene expression and virulence factors. This adaptability allows the fungus to thrive in various niches within the human body.

Identifying Candida Skin Infections: Visual Cues and Symptoms

Recognizing the signs of cutaneous candidiasis is essential for prompt diagnosis and treatment. Candida skin infections can manifest in various ways, depending on the affected area and the individual’s overall health. Common visual cues and symptoms include:

• Redness and inflammation of the affected skin
• Itching or burning sensation
• Small, red, sometimes pus-filled bumps
• Scaling or flaking of the skin
• Cracks or fissures in the skin, especially in skin folds
• White, patchy appearance in moist areas

Can Candida infections affect specific body areas differently? Yes, the presentation of cutaneous candidiasis can vary depending on the location:

1. Intertriginous candidiasis: Occurs in skin folds, such as under the breasts, in the groin area, or between fingers and toes.
2. Diaper rash: A common form of candidiasis in infants, characterized by red, irritated skin in the diaper area.
3. Oral thrush: While not a skin infection per se, this form of candidiasis affects the mucous membranes of the mouth and can extend to the corners of the lips.
4. Nail candidiasis: Infection of the nail bed, often presenting as discoloration and thickening of the nail.

Risk Factors and Predisposing Conditions for Candida Skin Infections

Several factors can increase an individual’s susceptibility to cutaneous candidiasis. Understanding these risk factors is crucial for prevention and management of Candida skin infections:

• Humidity and moisture: Prolonged exposure to damp conditions can create an environment conducive to Candida growth.
• Compromised immune system: Conditions such as HIV/AIDS, cancer, or use of immunosuppressive medications can increase vulnerability to fungal infections.
• Diabetes: Elevated blood sugar levels can promote Candida growth and impair immune function.
• Obesity: Excess skin folds create warm, moist areas where Candida can thrive.
• Antibiotic use: Broad-spectrum antibiotics can disrupt the normal skin flora, allowing Candida to overgrow.
• Poor hygiene: Inadequate personal hygiene can contribute to the proliferation of Candida on the skin.
• Tight-fitting clothing: Non-breathable fabrics can trap moisture and heat, creating an ideal environment for fungal growth.

Do nutritional deficiencies play a role in Candida infections? Research has shown that certain nutritional deficiencies, particularly iron deficiency, can increase susceptibility to Candida infections. Iron is crucial for proper immune function, and its deficiency can impair the body’s ability to fight off fungal overgrowth.

The Role of the Immune System in Combating Candida Infections

The immune system plays a pivotal role in preventing and controlling Candida infections. Various components of the immune response work together to recognize and eliminate Candida:

• Innate immunity: The skin’s physical barrier and antimicrobial peptides form the first line of defense against Candida.
• Pattern recognition receptors: These receptors, such as Toll-like receptors, recognize Candida-associated molecular patterns and initiate immune responses.
• T cells: Particularly Th17 cells, which produce interleukin-17 (IL-17), are crucial for antifungal immunity.
• Neutrophils: These white blood cells are important for phagocytosis and killing of Candida.

Why are some individuals more susceptible to chronic mucocutaneous candidiasis? Certain genetic mutations affecting immune function can predispose individuals to recurrent or persistent Candida infections. For example:

1. STAT1 gain-of-function mutations: These can lead to impaired Th17 responses and increased susceptibility to fungal infections.
2. IL-12 receptor deficiency: This condition can result in inadequate immune responses against Candida and other pathogens.
3. Chronic granulomatous disease: This inherited disorder affects the ability of certain immune cells to kill fungi and bacteria effectively.

Diagnosis and Differential Considerations for Candida Skin Infections

Accurate diagnosis of cutaneous candidiasis is essential for appropriate treatment. While visual inspection can provide initial clues, confirmatory tests are often necessary to differentiate Candida infections from other skin conditions:

• Microscopic examination: A skin scraping can be examined under a microscope to identify Candida yeast cells or hyphae.
• Culture: Samples can be cultured to identify the specific Candida species causing the infection.
• Molecular methods: PCR-based techniques can provide rapid and accurate identification of Candida species.
• Wood’s lamp examination: Although not specific for Candida, this can help differentiate fungal infections from other skin conditions.

What conditions might be mistaken for cutaneous candidiasis? Several skin conditions can present similarly to Candida infections:

1. Seborrheic dermatitis
2. Psoriasis
3. Eczema
4. Bacterial skin infections
5. Other fungal infections (e.g., dermatophytosis)

Proper diagnosis is crucial for implementing the most effective treatment strategy and avoiding unnecessary or inappropriate interventions.

Treatment Strategies for Cutaneous Candidiasis

The management of Candida skin infections typically involves a combination of topical and, in some cases, systemic antifungal treatments. The choice of therapy depends on the extent and severity of the infection, as well as any underlying conditions:

Topical Antifungal Treatments

• Azole antifungals: Creams, lotions, or powders containing clotrimazole, miconazole, or ketoconazole are often first-line treatments for localized infections.
• Nystatin: This polyene antifungal is effective against many Candida species and is available in various topical formulations.
• Ciclopirox: An alternative topical agent that can be effective against azole-resistant Candida strains.

Systemic Antifungal Treatments

For more extensive or resistant infections, oral antifungal medications may be prescribed:

• Fluconazole: A commonly used oral azole antifungal for systemic candidiasis.
• Itraconazole: Effective against a broad spectrum of fungal pathogens, including azole-resistant Candida species.
• Voriconazole: A second-generation triazole that can be used for resistant infections.

How long does it typically take for antifungal treatments to show results? While individual responses may vary, most patients begin to see improvement within a few days to a week of starting treatment. However, it’s important to complete the full course of therapy as prescribed to prevent recurrence.

Adjunctive Measures

In addition to antifungal therapy, several supportive measures can help manage cutaneous candidiasis:

• Keeping the affected area clean and dry
• Using barrier creams or powders in skin folds to reduce moisture
• Wearing loose-fitting, breathable clothing
• Managing underlying conditions, such as diabetes, that may contribute to infection

Are there any natural remedies that can help with Candida skin infections? While scientific evidence is limited, some individuals find relief with natural remedies such as tea tree oil or coconut oil, which have antifungal properties. However, these should not replace conventional treatments without medical supervision.

Prevention Strategies and Long-Term Management

Preventing recurrence and managing chronic candidiasis requires a comprehensive approach that addresses both immediate symptoms and underlying risk factors:

• Maintaining good hygiene practices, especially in warm and humid environments
• Using moisture-wicking fabrics and avoiding tight-fitting clothing
• Managing chronic health conditions, such as diabetes, that increase susceptibility to fungal infections
• Avoiding unnecessary antibiotic use, which can disrupt the skin’s natural microbial balance
• Strengthening the immune system through proper nutrition, regular exercise, and stress management
• Using prophylactic antifungal treatments in high-risk individuals or situations

Can dietary changes help prevent Candida overgrowth? While the link between diet and Candida infections is not fully established, some evidence suggests that reducing sugar intake and consuming probiotic-rich foods may help maintain a healthy balance of microorganisms on the skin and in the body.

For individuals with recurrent or chronic candidiasis, working closely with a healthcare provider to develop a personalized management plan is crucial. This may involve regular check-ups, ongoing antifungal therapy, and addressing any underlying immune dysfunction or other predisposing factors.

Emerging Research and Future Directions in Candida Management

The field of Candida research is continuously evolving, with new insights into pathogenesis, diagnosis, and treatment emerging regularly. Some exciting areas of current and future research include:

• Novel antifungal agents: Researchers are exploring new compounds and drug delivery methods to combat drug-resistant Candida strains.
• Immunotherapies: Developing treatments that enhance the body’s natural immune response to Candida infections.
• Microbiome modulation: Investigating how manipulating the skin’s microbiome can prevent or treat Candida overgrowth.
• Personalized medicine approaches: Tailoring treatments based on individual genetic profiles and specific Candida strains.
• Improved diagnostic tools: Developing rapid, accurate methods for identifying Candida species and determining antifungal susceptibility.

What potential breakthroughs might we see in Candida management in the coming years? While it’s difficult to predict specific outcomes, areas of promise include:

1. Targeted antifungal peptides that selectively eliminate Candida without disrupting beneficial microorganisms
2. Vaccines that provide long-term protection against Candida infections
3. Gene therapy approaches for individuals with genetic predispositions to chronic candidiasis
4. Advanced imaging techniques for early detection and monitoring of fungal infections

As our understanding of Candida biology and host-pathogen interactions deepens, we can anticipate more effective and personalized approaches to managing cutaneous candidiasis and other fungal infections.

Cutaneous Candidiasis: Background, Pathophysiology, Etiology

1. Gauch LMR, Pedrosa SS, Silveira-Gomes F, Esteves RA, Marques-da-Silva SH. Isolation of Candida spp. from denture-related stomatitis in Pará, Brazil. Braz J Microbiol. 2018 Jan – Mar. 49 (1):148-151. [QxMD MEDLINE Link].

2. De Bernardis F, Mühlschlegel FA, Cassone A, Fonzi WA. The pH of the host niche controls gene expression in and virulence of Candida albicans. Infect Immun. 1998 Jul. 66 (7):3317-25. [QxMD MEDLINE Link].

3. Staab JF, Bradway SD, Fidel PL, Sundstrom P. Adhesive and mammalian transglutaminase substrate properties of Candida albicans Hwp1. Science. 1999 Mar 5. 283 (5407):1535-8. [QxMD MEDLINE Link].

4. Buurman ET, Westwater C, Hube B, Brown AJ, Odds FC, Gow NA. Molecular analysis of CaMnt1p, a mannosyl transferase important for adhesion and virulence of Candida albicans. Proc Natl Acad Sci U S A. 1998 Jun 23. 95 (13):7670-5. [QxMD MEDLINE Link].

5. Mayer FL, Wilson D, Hube B. Candida albicans pathogenicity mechanisms. Virulence. 2013 Jan 9. 4(2):[QxMD MEDLINE Link].

6. Li M, Chen Q, Shen Y, Liu W. Candida albicans phospholipomannan triggers inflammatory responses of human keratinocytes through Toll-like receptor 2. Exp Dermatol. 2009 Jul. 18(7):603-10. [QxMD MEDLINE Link].

7. Shiraki Y, Ishibashi Y, Hiruma M, Nishikawa A, Ikeda S. Candida albicans abrogates the expression of interferon-gamma-inducible protein-10 in human keratinocytes. FEMS Immunol Med Microbiol. 2008 Oct. 54(1):122-8. [QxMD MEDLINE Link].

8. Swidergall M. Candida albicans at Host Barrier Sites: Pattern Recognition Receptors and Beyond. Pathogens. 2019 Mar 25. 8 (1):[QxMD MEDLINE Link].

9. Nielsen J, Kofod-Olsen E, Spaun E, Larsen CS, Christiansen M, Mogensen TH. A STAT1-gain-of-function mutation causing Th27 deficiency with chronic mucocutaneous candidiasis, psoriasiform hyperkeratosis and dermatophytosis. BMJ Case Rep. 2015 Oct 22. 2015:[QxMD MEDLINE Link].

10. Conti HR, Whibley N, Coleman BM, Garg AV, Jaycox JR, Gaffen SL. Signaling through IL-17C/IL-17RE is dispensable for immunity to systemic, oral and cutaneous candidiasis. PLoS One. 2015 Apr 7. 10(4):e0122807. [QxMD MEDLINE Link].

11. Campois TG, Zucoloto AZ, de Almeida Araujo EJ, Svidizinski TI, Almeida RS, da Silva Quirino GF, et al. Immunological and histopathological characterization of cutaneous candidiasis. J Med Microbiol. 2015 Aug. 64(8):810-7. [QxMD MEDLINE Link].

12. Sarkadi AK, Taskó S, Csorba G, Tóth B, Erdős M, Maródi L. Autoantibodies to IL-17A may be correlated with the severity of mucocutaneous candidiasis in APECED patients. J Clin Immunol. 2014 Feb. 34(2):181-93. [QxMD MEDLINE Link].

13. Lorenzini T, Dotta L, Giacomelli M, Vairo D, Badolato R. STAT mutations as program switchers: turning primary immunodeficiencies into autoimmune diseases. J Leukoc Biol. 2017 Jan. 101 (1):29-38. [QxMD MEDLINE Link].

14. Zimmerman O, Rösler B, Zerbe CS, Rosen LB, Hsu AP, Uzel G, et al. Risks of Ruxolitinib in STAT1 Gain-of-Function-Associated Severe Fungal Disease. Open Forum Infect Dis. 2017 Fall. 4 (4):ofx202. [QxMD MEDLINE Link].

15. Ouederni M, Sanal O, Ikinciogullari A, Tezcan I, Dogu F, Sologuren I, et al. Clinical features of Candidiasis in patients with inherited interleukin 12 receptor ß1 deficiency. Clin Infect Dis. 2014 Jan. 58(2):204-13. [QxMD MEDLINE Link]. [Full Text].

16. Arnold DE, Heimall JR. A Review of Chronic Granulomatous Disease. Adv Ther. 2017 Dec. 34 (12):2543-2557. [QxMD MEDLINE Link].

17. Henriet S, Verweij PE, Holland SM, Warris A. Invasive Fungal Infections in Patients with Chronic Granulomatous Disease. Curtis N, Finn A, Pollard AJ, eds. Hot Topics in Infection and Immunity in Children IX. Advances in Experimental Medicine and Biology. Springer New York; 2013. 27-55.

18. Heidrich D, Stopiglia CD, Magagnin CM, Daboit TC, Vettorato G, Amaro TG, et al. Sixteen Years of Dermatomycosis Caused by Candida spp. in the Metropolitan Area of Porto Alegre, Southern Brazil. Rev Inst Med Trop Sao Paulo. 2016. 58:14. [QxMD MEDLINE Link].

19. Sadeghi G, Ebrahimi-Rad M, Shams-Ghahfarokhi M, Jahanshiri Z, Ardakani EM, Eslamifar A, et al. Cutaneous candidiasis in Tehran-Iran: from epidemiology to multilocus sequence types, virulence factors and antifungal susceptibility of etiologic Candida species. Iran J Microbiol. 2019 Aug. 11 (4):267-279. [QxMD MEDLINE Link].

20. Jenkins WM, Macfarlane TW, Ferguson MM, Mason DK. Nutritional deficiency in oral candidosis. Int J Oral Surg. 1977 Aug. 6 (4):204-10. [QxMD MEDLINE Link].

21. Fourie R, Kuloyo OO, Mochochoko BM, Albertyn J, Pohl CH. Iron at the Centre of Candida albicans Interactions. Front Cell Infect Microbiol. 2018. 8:185. [QxMD MEDLINE Link].

22. Rodrigues CF, Rodrigues ME, Henriques M. Candida sp. Infections in Patients with Diabetes Mellitus. J Clin Med. 2019 Jan 10. 8 (1):[QxMD MEDLINE Link].

23. McGurk M, Holmes M. Chronic muco-cutaneous candidiasis and oral neoplasia. J Laryngol Otol. 1988 Jul. 102 (7):643-5. [QxMD MEDLINE Link].

24. Antachopoulos C. Invasive fungal infections in congenital immunodeficiencies. Clin Microbiol Infect. 2010 Sep. 16 (9):1335-42. [QxMD MEDLINE Link].

25. Pitchumoni CS, Dharmarajan T. Geriatric Gastroenterology. Springer Science & Business Media; 2012.

26. Öncü B, Belet N, Emecen AN, Birinci A. Health care-associated invasive Candida infections in children. Med Mycol. 2019 Nov 1. 57 (8):929-936. [QxMD MEDLINE Link].

27. Aruna C, Seetharam K. Congenital candidiasis. Indian Dermatol Online J. 2014 Nov. 5 (Suppl 1):S44-7. [QxMD MEDLINE Link].

28. Richardson JP, Naglik JR. Special Issue: Mucosal Fungal Infections. J Fungi (Basel). 2018 Mar 26. 4 (2):[QxMD MEDLINE Link].

29. Kashyap B, Das S, Gupta K, Sagar T. Current Scenario of Geriatric Fungal Infections: A Prevalence Study from East Delhi. Aging Med Healthcare. 2019. 10(1):46-50.

30. Flevari A, Theodorakopoulou M, Velegraki A, Armaganidis A, Dimopoulos G. Treatment of invasive candidiasis in the elderly: a review. Clin Interv Aging. 2013. 8:1199-208. [QxMD MEDLINE Link].

31. Khambadkone SM, Dixit KM, Divekar A, Joshi SM, Irani SF, Desai M. Congenital candidiasis. Indian Pediatr. 1996 Jun. 33 (6):512-6. [QxMD MEDLINE Link].

32. Jagtap SA, Saple PP, Dhaliat SB. Congenital cutaneous candidiasis: a rare and unpredictable disease. Indian J Dermatol. 2011 Jan. 56 (1):92-3. [QxMD MEDLINE Link].

33. Puel A, Cypowyj S, Maródi L, Abel L, Picard C, Casanova JL. Inborn errors of human IL-17 immunity underlie chronic mucocutaneous candidiasis. Curr Opin Allergy Clin Immunol. 2012 Dec. 12 (6):616-22. [QxMD MEDLINE Link].

34. Marazzi MG, Bondi E, Giannattasio A, Strozzi M, Savioli C. Intracranial aneurysm associated with chronic mucocutaneous candidiasis. Eur J Pediatr. 2008 Apr. 167 (4):461-3. [QxMD MEDLINE Link].

35. Cohen MS, Isturiz RE, Malech HL, Root RK, Wilfert CM, Gutman L, et al. Fungal infection in chronic granulomatous disease. The importance of the phagocyte in defense against fungi. Am J Med. 1981 Jul. 71 (1):59-66. [QxMD MEDLINE Link].

36. Denning DW, Kneale M, Sobel JD, Rautemaa-Richardson R. Global burden of recurrent vulvovaginal candidiasis: a systematic review. Lancet Infect Dis. 2018 Nov. 18 (11):e339-e347. [QxMD MEDLINE Link].

37. Ramirez De Knott HM, McCormick TS, Do SO, et al. Cutaneous hypersensitivity to Candida albicans in idiopathic vulvodynia. Contact Dermatitis. 2005 Oct. 53(4):214-8. [QxMD MEDLINE Link].

38. Swamiappan M, Chandran V, Ramasamy S, et al. Candidal balanoposthitis – A retrospective study in a tertiary care centre of South India. J Evolution Med Dent Sci. 2016. 5 (95):7042-7045. [Full Text].

39. Lisboa C, Santos A, Dias C, Azevedo F, Pina-Vaz C, Rodrigues A. Candida balanitis: risk factors. J Eur Acad Dermatol Venereol. 2010 Jul. 24 (7):820-6. [QxMD MEDLINE Link].

40. Gibney MD, Siegfried EC. Cutaneous congenital candidiasis: a case report. Pediatr Dermatol. 1995 Dec. 12(4):359-63. [QxMD MEDLINE Link].

41. Raval DS, Barton LL, Hansen RC, Kling PJ. Congenital cutaneous candidiasis: case report and review. Pediatr Dermatol. 1995 Dec. 12(4):355-8. [QxMD MEDLINE Link].

42. Hoppe JE. Treatment of oropharyngeal candidiasis and candidal diaper dermatitis in neonates and infants: review and reappraisal. Pediatr Infect Dis J. 1997 Sep. 16(9):885-94. [QxMD MEDLINE Link].

43. Ramos-E-Silva M, Lima CM, Schechtman RC, Trope BM, Carneiro S. Superficial mycoses in immunodepressed patients (AIDS). Clin Dermatol. 2010 Mar 4. 28(2):217-25. [QxMD MEDLINE Link]. [Full Text].

44. Navabi N, Gholamhoseinian A, Baghaei B, Hashemipour MA. Risk factors associated with denture stomatitis in healthy subjects attending a dental school in southeast iran. Sultan Qaboos Univ Med J. 2013 Nov. 13 (4):574-80. [QxMD MEDLINE Link].

45. Nico MM, Rivitti EA. Decubital candidosis’: a study of 26 cases. J Eur Acad Dermatol Venereol. 2005 May. 19(3):296-300. [QxMD MEDLINE Link].

46. Yanagisawa N, Suganuma A, Takeshita N, et al. [A case of disseminated candidiasis as an initial presentation of AIDS]. Kansenshogaku Zasshi. 2007 Jul. 81(4):459-62. [QxMD MEDLINE Link].

47. Biscaye S, Demonchy D, Afanetti M, Dupont A, Haas H, Tran A. Ecthyma gangrenosum, a skin manifestation of Pseudomonas aeruginosa sepsis in a previously healthy child: A case report. Medicine (Baltimore). 2017 Jan. 96 (2):e5507. [QxMD MEDLINE Link].

48. Xi L, Li X, Zhang J, Lu C, Xie T, Yin R. Good response in a patient with deep-seated subcutaneous ulcer due to Candida species. Mycopathologia. 2007 Aug. 164(2):77-80. [QxMD MEDLINE Link].

49. Luo DQ, Yang W, Wu LC, Liu JH, Chen WN. Interdigital ulcer: an unusual presentation of Candida infection. Mycoses. 2011 May 25. [QxMD MEDLINE Link].

50. Weiler L, Poulalhon N, Debarbieux S, Thomas L. Darier’s disease can be complicated by generalised cutaneous candidiasis: a case-report. Br J Dermatol. 2014 Aug 21. [QxMD MEDLINE Link].

51. Bolognia J, Jorizzo J, Schaffer J, eds. Dermatology. 3rd ed. Elsevier Saunders; 2012.

52. webmd.com”>Van L, Harting M, Rosen T. Jacquet erosive diaper dermatitis: a complication of adult urinary incontinence. Cutis. 2008 Jul. 82 (1):72-4. [QxMD MEDLINE Link].

53. Nobles T, Miller RA. Intertrigo. StatPearls [Internet]. 2019 Jan. [QxMD MEDLINE Link]. [Full Text].

54. Mohr MR, Erdag G, Shada AL, Williams ME, Slingluff CL Jr, Patterson JW. Two patients with Hailey-Hailey disease, multiple primary melanomas, and other cancers. Arch Dermatol. 2011 Feb. 147 (2):211-5. [QxMD MEDLINE Link].

55. Sharon V, Fazel N. Oral candidiasis and angular cheilitis. Dermatol Ther. 2010 May-Jun. 23 (3):230-42. [QxMD MEDLINE Link].

56. Eversole LR. Clinical Outline of Oral Pathology: Diagnosis and Treatment. Lea & Febiger; 2001.

57. webmd.com”>Weedon D, Patterson JW. Weedon’s Skin Pathology. 4th ed. Elsevier; 2015.

58. Raz-Pasteur A, Ullmann Y, Berdicevsky I. The pathogenesis of Candida infections in a human skin model: scanning electron microscope observations. ISRN Dermatol. 2011. 2011:150642. [QxMD MEDLINE Link]. [Full Text].

59. Spettel K, Barousch W, Makristathis A, Zeller I, Nehr M, Selitsch B, et al. Analysis of antifungal resistance genes in Candida albicans and Candida glabrata using next generation sequencing. PLoS One. 2019. 14 (1):e0210397. [QxMD MEDLINE Link].

60. Jeffery-Smith A, Taori SK, Schelenz S, Jeffery K, Johnson EM, Borman A, et al. Candida auris: a Review of the Literature. Clin Microbiol Rev. 2018 Jan. 31 (1):[QxMD MEDLINE Link].

61. Ostrowsky B, Greenko J, Adams E, et al. Candida auris Isolates Resistant to Three Classes of Antifungal Medications — New York, 2019. Centers for Disease Control and Prevention. Available at https://www.cdc.gov/mmwr/volumes/69/wr/mm6901a2.htm. January 10, 2020; Accessed: January 17, 2020.

62. Felipe LO, Júnior WFDS, Araújo KC, Fabrino DL. Lactoferrin, chitosan and Melaleuca alternifolia-natural products that show promise in candidiasis treatment. Braz J Microbiol. 2018 Apr – Jun. 49 (2):212-219. [QxMD MEDLINE Link].

63. Robatto M, Pavie MC, Garcia I, Menezes MP, Bastos M, Leite HJD, et al. Ultraviolet A/blue light-emitting diode therapy for vulvovaginal candidiasis: a case presentation. Lasers Med Sci. 2019 Dec. 34 (9):1819-1827. [QxMD MEDLINE Link].

64. Pericolini E, Gabrielli E, Ballet N, Sabbatini S, Roselletti E, Cayzeele Decherf A, et al. Therapeutic activity of a Saccharomyces cerevisiae-based probiotic and inactivated whole yeast on vaginal candidiasis. Virulence. 2017 Jan 2. 8 (1):74-90. [QxMD MEDLINE Link].

65. Roselletti E, Sabbatini S, Ballet N, Perito S, Pericolini E, Blasi E, et al. Saccharomyces cerevisiae CNCM I-3856 as a New Therapeutic Agent Against Oropharyngeal Candidiasis. Front Microbiol. 2019. 10:1469. [QxMD MEDLINE Link].

66. Relhan V, Goel K, Bansal S, Garg VK. Management of chronic paronychia. Indian J Dermatol. 2014 Jan. 59 (1):15-20. [QxMD MEDLINE Link].

67. Pappas PG, Kauffman CA, Andes DR, Clancy CJ, Marr KA, Ostrosky-Zeichner L, et al. Executive Summary: Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2016 Feb 15. 62 (4):409-17. [QxMD MEDLINE Link].

68. Evans EC, Gray M. What interventions are effective for the prevention and treatment of cutaneous candidiasis?. J Wound Ostomy Continence Nurs. 2003 Jan. 30 (1):11-6. [QxMD MEDLINE Link].

69. Kaufman D. Strategies for prevention of neonatal invasive candidiasis. Semin Perinatol. 2003 Oct. 27 (5):414-24. [QxMD MEDLINE Link].

3 Symptoms, Diagnosis, and Management of Candida

*This course has been retired. There is no replacement course at this time. Please click here to view the current ATrain course listings.

Clinical Symptoms

The clinical symptoms vary depending on the location affected by the yeast. From head to toe, the most common sites for fungal infections include the scalp, skin, mouth, gastrointestinal tract, genitourinary tract, vagina, and nail beds of the hands and feet. The most dangerous type of fungal infection is an invasive infection (or systemic infection) that enters the bloodstream; it is called candidemia.   Fungal infections that originate in the oral cavity and extend into the esophagus have a higher potential to become an invasive infection because they become systemic.

Classically, yeast infections look red, warm, sometimes scaly, and continue to spread if not treated. They can be itchy but not generally painful unless directly on the skin of the genitals and buttocks. They generally do not cause a fever but if not treated can cause a sense of malaise and gastrointestinal upset and bloating if in the GI tract. To review the specific symptoms, let’s look at each of them based on locations of the body.

Skin Infections

Topical skin infections include the scalp, head, face, back, chest, axilla, under the breast or in other skin folds, and anywhere on the body from head to toe. When a yeast infection develops on the skin it generally appears red, scaly and inflamed with symptoms of itching and burning, however unique configurations can occur that help diagnose the yeast. An example is the classic shape of a ringworm infection on the skin, called Tinea corporis. Ringworm is misnamed because there is no actual worm on the skin, rather the unique shape caused by the dermatophyte yeast. Superficial skin infections by yeast at the epidermis are caused by fungi called dermatophytes.

Internal Infections

Because yeast is very common as topical normal flora, skin infections can easily develop given the right environment. Additionally, the moist and warm internal environment of the body offers ideal growth for candida.

Vaginal Candidiasis

Speculum exam in candidal vulvovaginitis, showing thick, curd-like plaque on the anterior vaginal wall. A slightly erythematous base is visible close to the center of the image, where some of the plaque was scraped off. Mikael Häggström. Source: Wikimedia Commons. Creative Commons CC0 1.0 Universal Public Domain Dedication.

From head to toe, internal candida infections commonly occur in the mouth, known as oral thrush. It appears as a white sticky coating and can even appear hairy from the extensions of hyphae. It can be easily treated with an oral antifungal, such as a swish and swallow medication. Good oral hygiene for patients on ventilators and rinsing after taking an inhaled glucocorticoid can help prevent this.

Gastrointestinal yeast infections often present as GI bloating, nausea, vomiting, diarrhea and generalized malaise. In diets high in sugar, the GI yeast can easily grow and contribute to belly fat, constipation, poor metabolism of food, and further infection (García-Elorriaga & Rey-Pineda, 2013).

A very common internal yeast infection occurs in the vagina. Symptoms include vaginal itching, foul fishy odor, and white cottage-cheese–like discharge. Upon visualization using a speculum, it is easy to diagnose because of its white discharge. It can be cultured for definitive diagnosis, however, most clinicians will easily recognize it and treat it with antifungals intravaginally, or orally.

Skin yeast infections can also appear as a red, flat rash with scalloped edges. Satellite lesions are extensions of the original yeast that grow to extend the rash. As noted above, tinea infections are identified by their location on the body.

Diagnosing Candida

KOH Test on a Candida Specimen

KOH test on a vaginal wet mount showing slings of pseudohyphae of Candida albicans surrounded by vaginal epithelial cells conferring a diagnosis of candidal vulvovaginitis. Mikael Häggström. Source: Wikimedia Commons. Creative Commons CC0 1.0 Universal Public Domain Dedication.

Often a candida infection is easily identifiable but a definitive diagnosis can only be done via a microscope or culturing. A skin scraping or swab sampling can be placed under a microscope, which reveals the typical and classic hyphae or fern-like growths. A single drop of potassium hydroxide, KOH, is often added to the microscopic slide, which dissolves the human skin cell wall and exposes the yeast and identifiable hyphae.

When using the culture method, a simple sterile swab of the infected surface is wiped on the culture medium (e.g., a blood agar petri dish) and allowed to grow in an incubated temperature of 98.6ºF for several days. Yeast and bacterial colonies easily occur within 3 to 5 days. Because candida is part of the normal flora, identifying a true infection is based on the various candida species that may grow in an agar culture, the agar fermentation, and assimilation tests.

Agar Plate Culture of C. Albicans

Source: CDC Public Health Image Library. Public domain.

Clinicians can often recognize a yeast infection based on its location and classic morphology and do not order diagnostic tests but treat right away. For example, when a practitioner sees the classic ring worm formation a topical antifungal is ordered. Occasionally a clinician may observe the skin directly with an ultraviolet light known as a Wood’s lamp. The spores of the yeast become fluorescent with a Wood’s lamp and appear blue-green when exposed to ultraviolet light.

For invasive agents within the bloodstream, non-culture candida detection tests can be done with antigen testing such as the Beta-D-Glucan, or candida PCR, which detects candidal DNA. Candida heat-liable-antigen assays—D-arabinitol assay or D-inositol assay—can also be used based on the laboratory’s preference and equipment. Immunological tests such as skin tests can also be performed.

Treatment of Yeast

Prompt treatment is key to quick destruction of out of control yeast.

Pharmacological treatment of candida depends on the location. The severity of the fungal infection also dictates the type of antifungal to be used for treatment. An acute fungal infection on the skin can often easily be treated with topical antifungals, however if they have become extensive or chronic, often long-term topical agents in addition to oral agents need to be prescribed.

For most acute fungal skin infections, topical antifungals commonly used include:

• Clotrimazole (Lotrimin, Mycelex)
• Ketoconazole (Xolegel)
• Miconazole (aloe vesta antifungal, azolen, baza antifungal, carrington antifungal, critic aid clear, cruex prescription strength, dermafungal, desenex, fungoid tincture, micaderm, micatin, micro-guard, miranel, mitrazol, podactin, remedy antifungal, secura antifungal)
• Terbinafine (Lamisil)

Prescription topical agents for resistant or extensive infections may include:

• Ciclopirox (Loprox, Penlac)
• Ketoconazole (Nizoral)
• Oxiconazole (Oxistat)

Administration of these antifungals are generally via a cream that is applied twice daily for 2 to 4 weeks. The length of application depends of course on the severity of the yeast and if the infection is acute or chronic. A topical ringworm infection may require treatment for 14 days, however a topical great-toenail fungal infection may require months of treatment and be very difficult to get rid of as the yeast have become embedded in the matrix of the nail.

For chronic yeast infections, an oral antifungal should be given and may include (Jaliman, 2019):

• Fluconazole (Diflucan)
• Griseofulvin (Fulvicin P/G, Fulvicin U/F, Grifulvin V, Gris-Peg): oral and spray. May need 8-10 weeks for effect. Cannot take during pregnancy or breastfeeding. May cause birth defects. Men should use condoms for up to six months after treatment to prevent birth defects.
• Itraconazole (Sporanox): 1-2 weeks. Not for use in elderly and children with liver disease.
• Ketoconazole (Nizoral)
• Terbinafine (Lamisil): once daily x 4 weeks

All oral antifungals are processed by the liver’s first-pass effect, which may cause nausea, diarrhea, indigestion, headache, dizziness, and even rashes. These oral antifungals are contraindicated for those with liver disease and lupus.

For severe fungal infections that impact a mechanical device, prescription IV antibiotics that are used include:

• Amphotericin
• Azole antifungals
• Echinocandins such as micafungin

Removal of the mechanic device or tube should also be a priority to avoid entry of the pathogen into the bloodstream.

Alternative medicines and folk medicine have been used to treat yeast infections. Although not endorsed by the American Medical Association, patients may be using these remedies and healthcare professionals should be aware of them. Many studies exist demonstrating the effectiveness of various essential oils(e.g., oregano oil) and even food substances (Alves-Silva, 2013). Studies have even shown effectiveness of apple cider vinegar against topical and intestinal yeasts.

Back Next

Candidal stomatitis – symptoms and signs

Abramyan Narine Leonidovna

Pediatric dentist

Experience:

6 years

Reviews:

2

m. Textile workers

Agayev Emin Rafer Ogly

Orthopedist

Experience:

5

years

Reviews:

m. Youth

Azhimova (Dushanova) Assel Kayredinovna

Children’s orthodontist

Experience:

4

years

Reviews:

3

m. Textile workers

m. New Cheryomushki

Akimova Violetta Vadimovna

Children’s dentist

Experience:

12

years

Reviews:

6

Marina Roshcha

Aksenova Irina Anatolyevna

Orthodontist, leading specialist

Seniority:

23

Reviews:

30

m. VDNKh

m. Textile workers

Alexandrova Alexandra Andreevna

Orthodontist

Experience:

4

Reviews:

2

m. Youth

Alpatskaya Ekaterina Olegovna

Children’s dentist

Experience:

12 years

Reviews:

5

m. Youth

Arkhipova Anastasia Mikhailovna

Dentist-surgeon, dental implantologist, leading specialist

Experience:

8

years

Reviews:

13

m. Baltiyskaya

Ekaterina Afonina

Dentist-therapist

Experience:

7

years

Reviews:

2

m. VDNH

Akhtyamova Dilyara Amirkhanovna

Children’s dentist. Head of the Dental Department in Pediatric Dentistry at Volgogradsky Prospekt

Experience:

9 years

Reviews:

3

m. Textile workers

Atskanova Amina Arsenovna

Children’s dentist

Experience:

10

years

Reviews:

3

m. Textile workers

Bakutsky Vladimir Vladimirovich

Orthopedist

Experience:

14

years

Reviews:

4

m. VDNH

Doctors not found. Change the filtering options.

Candida in humans: symptoms of candida, treatment for candida, photo of candida

What is candida?

Candida is a genus of yeast with many species. Candida must be distinguished from mold – these are different microorganisms, although they belong to the same kingdom (mushrooms). Candida is found everywhere, is a symbiont of many animals and humans. Candida fungus is opportunistic – despite the fact that in a healthy body the microorganism may not manifest itself in any way, the slightest hormonal shift or a decrease in immunity leads to the development of candidiasis: a dangerous disease that can affect various organs and tissues.

Structure and reproduction

What does candida look like? Mushrooms of the genus Candida have a somewhat elongated shape and, under favorable conditions, are able to form a false mycelium (mycelium), consisting of elongated cells. The peculiarities of Candida representatives include the fact that they are able to form only chlamydospores, which are not true spores, but, nevertheless, have an improved defense mechanism. In fact, this form of existence of candida resembles cysts formed by some bacteria: chlamydospores have a dense outer shell that protects the fungus from aggressive environmental factors.

Spores play a significant role in the spread of candida, since in this form the fungus can remain viable in the environment for a long time until it enters the body of a new host. Fungi reproduce by budding. Candida mushrooms, like many others, are sensitive to the acid-base balance and are able to change it in their favor. The most favorable conditions for the development of microorganisms are slightly alkaline or neutral, therefore, answering the question, “what is Candida afraid of?”, It can be argued that the fungus dies in an acidic environment.

Candida in the human intestine

Candida is found in the intestines of more than 80% of people, and at the same time it does not always manifest itself as a pathogenic microorganism. Like many other yeast cultures, candida is actively involved in the enzymatic processes that occur in the small intestine, for example, it helps to process excess sugar. But, unlike many other species that make up the beneficial intestinal microflora, Candida is an aggressive fungus and numerous external and internal factors are capable of triggering the mechanism of its active reproduction. And then the patient develops candidiasis – a disease that can lead to many unpleasant consequences.

The following factors can provoke the rapid development of candida:

• Taking a course of antibiotics.
  Antibiotics not only destroy viruses and bacteria, but also suppress the intestinal microflora, giving the green light to the development of candida. Therefore, against the background of such therapy, candidiasis often develops.
• Conditions associated with reduced immunity.
  These include early childhood and old age, pregnancy, stress, and so on. Immunity is also reduced against the background of allergies, after respiratory diseases, which can also provoke candidiasis.
• Undergoing aggressive therapy.
  For example, in the treatment of cancer. In general, taking any strong medication affects homeostasis and contributes to the active development of candida.
• Imbalance of micro and macro elements.
  According to experts, any, sometimes even the most insignificant external or internal influence can cause active growth and development of candida. It is important to know that candida lives not only in the intestines. This fungus is also found in the oral cavity, on the mucous membranes of the genital organs of women and men, therefore, several types of fungal invasion are distinguished, each of which is accompanied by its own unique clinical picture.

Candida symptoms in the intestines

Any shift in the internal balance of the body can lead to the active reproduction of the fungus. It becomes dominant and suppresses the beneficial intestinal microflora, disrupting the normal enzymatic activity of the gastrointestinal tract and adversely affecting the absorption of most nutrients. Candida infection in the intestines is manifested by the following symptoms:

• Bloating and flatulence;
• Violation of defecation: stool becomes infrequent, but liquid, possibly frothy;
• The appearance of abdominal pain of varying severity.

With the chronicity of the disease, the symptoms become more pronounced, a serious imbalance of micro- and macroelements is added to them, the waste products of the fungus accumulate in the body, which are poisonous to humans. All this leads to inflammation of the intestine, deterioration of its functions, disruption of peristalsis and enzymatic activity. Against the background of weakened immunity, concomitant diseases (for example, gastroenteritis) may develop.

Candida in the mouth

Another common form of candida infection is associated with the explosive growth of fungus in the oral cavity. It can be provoked not only by weakened immunity, but also, for example, by some bad habits (smoking), regular wearing of dentures, choosing inappropriate oral hygiene products, etc. The most characteristic symptom of candidiasis is the lining of the tongue with white flakes, resembling cottage cheese in consistency. Visible tissue irritation is observed (blush, itch), taste sensations may change, cracks may form on the tongue or in the corners of the lips.

Treatment of candida in the tongue should be thoughtful and complex, since this disease is prone to a chronic course. Improper therapy leads only to a temporary suppression of candida in the oral cavity, but after a while the fungus returns, causing a lot of trouble for the patient.

Candida on the skin and mucous membranes

Candida, which is often mistaken for a virus, can be localized on the mucous membranes of the genital organs. This manifestation is called “thrush” and, contrary to popular belief, not only women suffer from it. The disease manifests itself as itching in the groin, redness of the mucous membranes, the appearance of a whitish coating, and women and men may feel discomfort (pain, itching) during intercourse and urination.

If candida infects the dermis, then the symptoms of invasion can be even more unpleasant. Patients complain of redness of the skin, it itches and becomes sensitive to touch, gets wet, and an unpleasant odor appears. Most often, the most delicate areas of the skin suffer from the fungus: between the toes and hands, in the groin area.

Candida treatment

How to identify candida? Depending on the type of infection, various laboratory research methods are used.